SCHEMBL1242360

SCHEMBL1242360

N=C(N)NC(=O)c1ccccc1I

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
PARP1 P09874 1/20 0.40
RXFP1 Q9HBX9 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
F2 P00734 1/20 0.37
F10 P00742 1/20 0.37
PLG P00747 1/20 0.37
PLAU P00749 1/20 0.37
PLAT P00750 1/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 2/20 0.37
NPC1 O15118 2/20 0.37
ABL1 P00519 1/20 0.37
SRC P12931 1/20 0.37
KDM4E B2RXH2 2/20 0.37
CA9 Q16790 2/20 0.36
CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3070336 0.86 ALDH1A1 (0.42) F2F10PLGPLAUPLAT
SCHEMBL28549913 0.86 MEN1 (0.39) MEN1KMT2ATDP1PARP1F2
SCHEMBL15417609 0.85 MEN1 (0.61) MEN1KMT2ATDP1PARP1RXFP1
SCHEMBL12903506 0.81 ALDH1A1 (0.56) MEN1KMT2ATDP1PARP1RXFP1
SCHEMBL23875051 0.79 CA1 (0.58) MEN1KMT2ATDP1F2F10
SCHEMBL8634908 0.79 RAB9A (0.50) KMT2ATDP1ALDH1A1MAPTHPGD
SCHEMBL8416208 0.78 POLB (0.60) MEN1KMT2AALDH1A1HPGDNPC1
SCHEMBL6651792 0.78 HPGD (0.53) KMT2AALDH1A1MAPTHPGDNPC1
SCHEMBL27393236 0.78 NPC1 (0.62) MEN1KMT2ATDP1ALDH1A1MAPT
SCHEMBL3073042 0.77 PLAU (0.39) F2F10PLGPLAUPLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3268052-A1 PREPARATIONS OF META-IODOBENZYLGUANDINE AND PRECURSORS THEREOF Molecular Insight Pharmaceuticals, Inc. (US) 2018-01-17 EP claimed
EP-3600453-A1 RADIOLABELED BIOMOLECULES AND THEIR USE Duke University (US) 2020-02-05 EP disclosed
WO-2018178936-A1 RADIOLABELED BIOMOLECULES AND THEIR USE DUKE UNIVERSITY (US) 2018-10-04 WO disclosed
EP-3268052-A1 PREPARATIONS OF META-IODOBENZYLGUANDINE AND PRECURSORS THEREOF Molecular Insight Pharmaceuticals, Inc. (US) 2018-01-17 EP disclosed
EP-2655295-A1 RADIOIODINATED GUANIDINES GE Healthcare UK Limited (GB) 2013-10-30 EP disclosed
EP-2643023-A1 RADIOIODINATION METHOD GE Healthcare UK Limited (GB) 2013-10-02 EP disclosed
EP-2509638-A1 IODINE RADIOLABELLING METHOD GE Healthcare UK Limited (GB) 2012-10-17 EP disclosed
WO-2012084928-A1 RADIOIODINATED GUANIDINES GE HEALTHCARE LIMITED (GB) 2012-06-28 WO disclosed
EP-2467365-A1 RADIOIODINATION METHOD GE Healthcare Limited (GB) 2012-06-27 EP disclosed
WO-2012069535-A1 RADIOIODINATION METHOD GE HEALTHCARE LIMITED (GB) 2012-05-31 WO disclosed
WO-2011070136-A1 IODINE RADIOLABELLING METHOD GE HEALTHCARE LIMITED (GB) 2011-06-16 WO disclosed
WO-2011020907-A1 RADIOIODINATION METHOD GE HEALTHCARE LIMITED (GB) 2011-02-24 WO disclosed
EP-2114873-A2 LIGANDS FOR IMAGING CARDIAC INNERVATION Lantheus Medical Imaging, Inc. (US) 2009-11-11 EP disclosed
WO-2008121322-A1 A METHOD OF TREATING NEUROBLASTOMA DUKE UNIVERSITY (US) 2008-10-09 WO disclosed
WO-2008083056-A2 LIGANDS FOR IMAGING CARDIAC INNERVATION LANTHEUS MEDICAL IMAGING, INC. (US) 2008-07-10 WO disclosed
EP-1901783-A1 GENTISIC ACID FOR STABILISIG 123-I RADIOPHARMACEUTICALS GE Healthcare UK Limited (GB) 2008-03-26 EP disclosed
WO-2007007021-A1 GENTISIC ACID FOR STABILISIG 123-I RADIOPHARMACEUTICALS GE HEALTHCARE LIMITED (GB) 2007-01-18 WO disclosed
EP-1185316-A1 DEVICES AND COMPOUNDS FOR TREATING ARTERIAL RESTENOSIS Cardio Vascular Solutions Inc. (CA) 2002-03-13 EP disclosed
WO-2000074742-A1 DEVICES AND COMPOUNDS FOR TREATING ARTERIAL RESTENOSIS CARDIO VASCULAR SOLUTIONS INC. (CA) 2000-12-14 WO disclosed